Genetic Test Reveals More About Potential Birth Defects Than Conventional Methods

Posted on by

Lawrence LeBlond for redOrbit.com - Your Universe Online Two new papers published in the New England Journal of Medicine ( NEJM ) show that genetic testing in early pregnancy reveals far more about potential birth defects and stillbirth risk than current prenatal testing does, based on a multi-center clinical trial using both methods. The clinical trials showed that 6 percent of certain fetuses ...

Read the original here:

Genetic Test Reveals More About Potential Birth Defects Than Conventional Methods

Gene Therapy for Eye Diseases – Dr. Donald J. D’Amico – Video

Posted on by


Gene Therapy for Eye Diseases - Dr. Donald J. D #39;Amico
Donald J. D #39;Amico, MD, the Ophthalmologist-in-Chief at New York Presbyterian/Weill Cornell Medial Center, talks about gene therapy as a potential treatment for eye diseases. You can learn more about Dr. D #39;Amico at: nyp.orgFrom:ORLivedotcomViews:1 0ratingsTime:01:55More inScience Technology

Read more:

Gene Therapy for Eye Diseases - Dr. Donald J. D'Amico - Video

Nuvilex Subsidiary, Austrianova Singapore, Publishes Advantages of its Encapsulated Cell Therapy for the Cell-Based …

Posted on by

SILVER SPRING, Md., Dec. 5, 2012 (GLOBE NEWSWIRE) -- Nuvilex, Inc. (NVLX), an international biotechnology provider of cell and gene therapy solutions, announced today its subsidiary Austrianova Singapore (ASPL) has published a new manuscript that describes the use of the Company's proprietary cell encapsulation technology for studies designed to create a cell based therapeutic treatment for diabetes.

The publication in the Wiener Medizinische Wochenschrift Skriptum, entitled "Cell encapsulation for the treatment of diabetes" was co-authored with Dr. Eva Brandtner, former ASPL Chief Scientific Officer who is presently at the Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT) in Austria. The manuscript outlines the advantages of using cellulose sulfate for the encapsulation of cells for treatment of diabetes. The article accompanied an invited presentation on the same topic at the Diabetes Meeting in Salzburg, Austria also given by Dr. Brandtner.

ASPL and VIVIT have planned and are working closely together to advance and develop the diabetes treatment using encapsulated cells capable of expressing insulin after they detect the presence of glucose. Ultimately, the aim is to place insulin-secreting cells encapsulated in cellulose sulphate in patients with diabetes to replace the patient's own cells that no longer secrete insulin in response to elevated levels of glucose. As a result, the encapsulated cells thereby replace the normal pancreatic cells and enable the body to function normally, preventing exposure to the debilitating effects of high levels of glucose in the body.

The CEO of ASPL, Dr. Brian Salmons, said, "We are very happy to have been able to release our data through this publication from our testing of the encapsulated live cell treatment potential for diabetes. Being able to continue our work with VIVIT and Dr. Eva Brandtner, will greatly enhance our ability to develop and advance diabetes treatments."

The President and CEO of Nuvilex, Dr. Robert Ryan, stated "Our commitment to create valuable patient treatments through the proprietary cell encapsulation developed over so many years by ASPL, including treatments for diabetes, has become stronger over the past year. The important advances made have been through the funding provided by Nuvilex this past year and will prove valuable in the coming years. Clearly the ability to treat patients with this disease is a major driving force for our companies. From a market perspective, the World Health Organization has shown that the economic benefits will be substantial as the costs of diabetes are presently estimated to be over $350 Billion dollars spent annually per year worldwide."

About Nuvilex

Nuvilex, Inc. (NVLX) is an international biotechnology provider of live therapeutically valuable, encapsulated cells and services for research and medicine. Important advances are moving Nuvilex and Austrianova Singapore forward. New developments by our company and subsidiaries will be substantial as we have been working on many fronts to move us forward. We hope to bring some of these to light very soon. Our company's clinical offerings will include cancer, diabetes and other treatments using the company's cell and gene therapy expertise and live-cell encapsulation technology.

The Nuvilex, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=13494

Safe Harbor Statement

This press release contains forward-looking statements described within the 1995 Private Securities Litigation Reform Act involving risks and uncertainties including product demand, market competition, and meeting current or future plans which may cause actual results, events, and performances, expressed or implied, to vary and/or differ from those contemplated or predicted. Investors should study and understand all risks before making an investment decision. Readers are recommended not to place undue reliance on forward-looking statements or information. Nuvilex is not obliged to publicly release revisions to any forward-looking statement, reflect events or circumstances afterward, or disclose unanticipated occurrences, except as required under applicable laws.

Originally posted here:

Nuvilex Subsidiary, Austrianova Singapore, Publishes Advantages of its Encapsulated Cell Therapy for the Cell-Based ...

uniQure Appoints Hans Christian Rohde Chief Commercial Officer

Posted on by

AMSTERDAM, The Netherlands, December 6, 2012 /PRNewswire/ --

uniQure B.V., a leader in the field of human gene therapy, today announced the appointment of Hans Christian Rohde as Chief Commercial Officer.

Mr. Rohde joins uniQure from Basilea Pharmaceutica (SIX:BSLN) where from 2007 he was Chief Commercial Officer and member of the company's executive management committee with responsibility for global commercial operations, marketing, supply chain, medical affairs, pricing and market access.

"We are very pleased with Hans Christian's appointment," says Jrn Aldag, CEO of uniQure. "With the approval of Glybera we need to rapidly build and expand our commercial organization to enable the successful roll-out of Glybera and provide access to this crucial treatment to as many patients as possible. Hans Christian's experience and successful track-record in major biotechnology companies such as Basilea, Merck-Serono and Biogen Idec provide us with the necessary leadership qualities to successfully commercialize Glybera."

Hans Christian Rohde (M.Sc., MBA) has almost 25 years experience in commercial roles at leading biotechnology and pharmaceutical companies. Prior to Basilea Pharmaceutica, Mr. Rohde was Corporate Vice President, Head of Global Therapeutic Areas Reproductive Health and Endocrinology at Merck-Serono from 2003 until 2007. Before this he was responsible for international marketing and global market development at Biogen Idec. From 1992 until 2000, Mr Rohde held positions of increasing commercial responsibility at Novo Nordisk. Mr. Rohde started his career at Laboratoires Syntex.

About uniQure

uniQure is a world leader in the development ofhuman gene based therapies.uniQure's Glybera, a gene therapy for the treatment of lipoprotein lipase deficiency has been approved in the European Union, and is the first approved gene therapy in the Western world. uniQure's product pipeline of gene therapy products in development comprise hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. Using adeno-associated viral (AAV) derived vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate probably the world's first stable and scalable AAV manufacturing platform.This proprietary platform can be applied to a large number of rare(orphan) diseases caused by one faulty gene. uniQure's largest shareholders are Forbion Capital Partners and Gilde Healthcare, two of the leading life sciences venture capital firms in the Netherlands. Further information can be found at http://www.uniqure.com.

About Glybera

uniQure has developed Glybera as a therapy for patients with the genetic disorder lipoprotein lipase deficiency, an orphan disease. The disease is caused by mutations in the LPL gene, resulting in highly decreased or absent activity of LPL enzyme in patients. This enzyme is needed in order to break down large fat-carrying particles that circulate in the blood after each meal. When such particles, called chylomicrons, accumulate in the blood, they may obstruct small blood vessels. Excess chylomicrons result in recurrent and severe acute inflammation of the pancreas, called pancreatitis, the most debilitating complication of LPLD. Glybera has orphan drug designation in the EU and US, and obtained marketing authorisation from the European Commission for commercialization in the 27 EU countries in November, 2012, making it the first gene therapy to win approval in the Western world.

Read this article:

uniQure Appoints Hans Christian Rohde Chief Commercial Officer

The Past: A Century of Teaching with Technology – Video

Posted on by


The Past: A Century of Teaching with Technology
Technology has been used to enhance learning and teaching for over one hundred years. Most Faculty and Instructional Technologists are focused on current and future technology and often do not have a century old perspective on the interplay of learning theory and mass communications technology. Dr Henry J. Burnett, although primarily a Futurist, is a scholar of Instructional Technology and Mass Media. Professor James Bierman will trace several stages of digital content development leading to the Internet Age. Time travel to the not so distant past and understand the early beginnings of Instructional Technology in Higher Education. (Note: This presentation will be based on the writings of Paul Saettler, CSU, Sacramento Professor of History, A History of Instructional Technology (1968) and The Evolution of American Educational Technology (1990).From:Henry BurnettViews:3 0ratingsTime:33:04More inEducation

See the article here:

The Past: A Century of Teaching with Technology - Video

Drum And Bass 2012 Neuro Tech Dark Mix (Free Download) [HQ] – Video

Posted on by


Drum And Bass 2012 Neuro Tech Dark Mix (Free Download) [HQ]
(tinyurl.com to download audio!) It was about time to do a new neuro mix, so here it is, enjoy! Rate or slate. Subscribe 😉 1. Cause4Concern - Alchemist 2. AI Command Strange - Mad One 3. Trace - Sonar (Duracell Remix) 4. State Of Mind - Azwell 5. Duracell - Lean 6. Naibu - Into The Distance (Break Remix) 7. Tokyo Prose Phil Tangent - Parity (Klute Remix) 8. Clarity - Cold Blank 9. Ulterior Motive Lenzman - Catharsis 10. Unknown Error - War Games (Donny Remix) 11. Gridlok feat. Mindscape - Chrome 12. Vicious Circle - Instinct 13. Mizo - Abyss 14. Rregula - Midnight World 15. The Upbeats - Undertaker 16. Monti - Caged (Rusher Remix) 17. Ibunshi Kodama - Fragments 18. Intelligent Manners Dynamic - Down With This 19. Mizo - Brain Cleave 20. Cause4Concern - Outlands 21. Futurist - Overstory 22. Chris Su Falkon - Disorientated 23. Dom Roland - Goliath 24. Jubei Ulterior Motive - Snore Tooth 25. Kantyze Rico - Anode 26. Place 2B Paimon - Beyond 27. June Miller - Turning Point 28. Dom Roland - Strobe 29. Naibu Hydro - Apparitions http://www.facebook.comFrom:ollieduracellViews:3 1ratingsTime:01:01:49More inMusic

Go here to read the rest:

Drum And Bass 2012 Neuro Tech Dark Mix (Free Download) [HQ] - Video

What is a Futurist – Video

Posted on by


What is a Futurist
What is a futurist? Consultant and futurist, Olive Gatling (Adjunct Professor - University of Texas-Austin Professional Development Center), shares a brief overview of this answer. Futurists make great consultants to assist organizations in shaping their strategy. Visit us at http://www.g-squaredbms.com to learn more about our creative niche!From:ogatlingViews:2 0ratingsTime:01:54More inEducation

Read more from the original source:

What is a Futurist - Video

Neil deGrasse Tyson Gets Philosophical with Futurist Jason Silva – Video

Posted on by


Neil deGrasse Tyson Gets Philosophical with Futurist Jason Silva
Are we a way for the cosmos to know itself? Or is that merely the hubris of humanity? Neil deGrasse Tyson, astrophysicist, host of StarTalk Radio and director of the Hayden Planetarium gets philosophical with futurist Jason Silva backstage before StarTalk Live at The Business Insider IGNITION Conference November 27, 2012.From:startalkradioViews:3881 130ratingsTime:01:21More inScience Technology

Read more:

Neil deGrasse Tyson Gets Philosophical with Futurist Jason Silva - Video

What makes us successful: Gerd Leonhard at TEDxCollegeBeauSoleil – Video

Posted on by


What makes us successful: Gerd Leonhard at TEDxCollegeBeauSoleil
Gerd is a Futurist and the CEO of The Futures Agency, author of 5 books, former musician and a globe-trotting keynote speaker on the creative industries, media and communications, social technologies, as well as on energy, the environment and green business. Gerd is currently focussing on sustainable future scenarios and what has been called #39;sustainable economics #39;, including the idea of adapting Internet and networked-society principles to the world #39;s urgent climate and environment issues. He is based in Basel / Switzerland; his new book #39;From Ego to Eco #39; will be published in 2013. In thespirit of ideas worth spreading, TEDx is a program of local, self-organized events that bring people together to share a TED-like experience. At a TEDx event, TEDTalks video and live speakers combine to spark deep discussion and connection in a small group. These local, self-organized events are branded TEDx, where x = independently organized TED event. The TED Conference provides general guidance for the TEDx program, but individual TEDx events are self-organized.* (*Subject to certain rules and regulations)From:TEDxYouthViews:5 0ratingsTime:13:05More inEducation

Original post:

What makes us successful: Gerd Leonhard at TEDxCollegeBeauSoleil - Video

Nebulous Mechanisms (the beginings of Creative Science) – Video

Posted on by


Nebulous Mechanisms (the beginings of Creative Science)
This video is a recording of the first reading of a Science Fiction Prototype written by Brian David Johnson (Intel #39;s Futurist) and presented at the Intelligent Environments conference in Barcelona, Spain in July 2009. The presentation is somewhat amateurish and long (even the camera team get bored and start pointing the camera at other "more interesting" activities). So, this is just here as a historical record and is not recommended for viewing by anyone other than those involved!. Later Brian Johnson went on to write a series of Science Fiction Prototypes which are published by O #39;Reilly and led to setting up the Creative Science Foundation. For more information see http://www.creative-science.orgFrom:vcallghanViews:1 0ratingsTime:20:18More inScience Technology

Original post:

Nebulous Mechanisms (the beginings of Creative Science) - Video

Keen On… Ray Kurzweil Talks About His New Book – Video

Posted on by


Keen On... Ray Kurzweil Talks About His New Book
Andrew Keen interviews futurist and author Ray Kurzweil, the author of "How To Create A Mind." His latest book compares the intelligence of humans vs machines and highlights differences and potential similarities between the two.From:techcrunchViews:18 2ratingsTime:12:11More inScience Technology

More:

Keen On... Ray Kurzweil Talks About His New Book - Video

Muse – Futurism – Video

Posted on by


Muse - Futurism
ignorance pulls apostasy and apathy still rules yeah you know it #39;s cool just suck and see a future turn us into silent Gods and I won #39;t miss you at all grounded boxed in like the evil in your viens grounded boxed in I am stuck with you fate can #39;t decide alignment of the planets in your hands [ Lyrics From - lyricsbird.net ] just suck and see a future that won #39;t let you disagree and I wont miss you at all grounded boxed in like the evil in your viens grounded boxed in feeling feeling everything feeling feeling everythingFrom:YABI SONViews:1 0ratingsTime:03:28More inMusic

More here:

Muse - Futurism - Video

Resaturate – Video

Posted on by


Resaturate
BVW Round 2 Fall 2012 Entertainment Technology Center Team: Alex Loughran Yang Shi Himanshu Vartak Christian Cashman Concept: Create a consistent, highly interactive, and engaging experience that lets guests feel like they have a lot of freedom in the choices they make. The game has to be experienced by a naive guest, who may or may not have played computer games. Only one verbal instruction can be given to the guest during gameplay. Game: Direct the colored ball in the environment, across obstacles to reach the basin in the final room. Complete three colors, R,G,B to take on the multicolored, multi-platform, final room.From:dj2neoViews:0 0ratingsTime:06:55More inEducation

See the article here:

Resaturate - Video

Free Tibet Project_Multimedia Storytelling – Video

Posted on by


Free Tibet Project_Multimedia Storytelling
This is a short video I created for my Multimedia Storytelling Class at the IAIA. It #39;s a video regarding the self-immolations that is taking place in Tibet. People are burning themselves as a strong protest against the Chinese occupation. They are seeking for religious freedom and equal treatment for the Tibetan people. Tibetans want their Holy HIghness Dalai Lama to return Tibet and to stop the torture on Tibetans. The video is dedicated to the Tibetan People. My humble prayers for the lost souls. Thanks to http://www.freetibet.org for letting me use some their photographs. I do not own any of the sound, music or videos. Most of the videos that I used are from youtube videos. I used some of the files from http://www.morguefile.com. I too have incorporated some of the videos and photographs that I took myself during different events organized by the Tibetan Association in Santa Fe, NM. My main focus was on letting people know about what #39;s happening in Tibet. And to raise voice for maintaining humanity in and for Tibet.From:psychodeepsViews:0 0ratingsTime:05:30More inNews Politics

See the article here:

Free Tibet Project_Multimedia Storytelling - Video